Get started

J-Pharma Co., Ltd. (Japan)

Alternate names: J-Pharma, J-Pharma Co., Ltd., ジェイファーマ株式会社
ROR: 05b2z2644
OpenAlex ID: I4405265632
Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in Humans
2008 · Naohiko Anzai, Kimiyoshi Ichida, et al. · Journal of Biological Chemistry · 361
l ‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth
2009 · Koji Oda, Noriko Hosoda, et al. · Cancer Science · 274
PDF
LAT1 Is a Critical Transporter of Essential Amino Acids for Immune Reactions in Activated Human T Cells
2013 · Keitaro Hayashi, Promsuk Jutabha, et al. · The Journal of Immunology · 202
First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors
2020 · Naohiro Okano, Daisuke Naruge, et al. · Investigational New Drugs · 179
The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
2018 · Yann Cormerais, Pierre André Massard, et al. · Journal of Biological Chemistry · 177
PDF
Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc
2019 · Yongchan Lee, Pattama Wiriyasermkul, et al. · Nature Structural & Molecular Biology · 175
PDF
Human Sodium Phosphate Transporter 4 (hNPT4/SLC17A3) as a Common Renal Secretory Pathway for Drugs and Urate
2010 · Promsuk Jutabha, Naohiko Anzai, et al. · Journal of Biological Chemistry · 158
PDF
L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia
2014 · C Rosilio, M Nebout, et al. · Leukemia · 128
High expression of L‐type amino‐acid transporter 1 (LAT1) in gastric carcinomas: Comparison with non‐cancerous lesions
2011 · Masaaki Ichinoe, Tetuo Mikami, et al. · Pathology International · 125
Metabolism and Pharmacokinetic Studies of JPH203, an L-Amino Acid Transporter 1 (LAT1) Selective Compound
2011 · Michael F. Wempe, Peter J. Rice, et al. · Drug Metabolism and Pharmacokinetics · 108
Strategic Plan of General Administration of Pharmaceutical Care at Ministry of Health in Saudi Arabia 2012 – 2022
2015 · Yousef Ahmed Alomi · Journal of Pharma & Pharmaceutical Sciences · 107
PDF
c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells
2012 · KEITARO HAYASHI, PROMSUK JUTABHA, et al. · Oncology Reports · 86
PDF
Establishment and Characterization of Mammalian Cell Lines Stably Expressing Human L-Type Amino Acid Transporters
2008 · Emiko Morimoto, Yoshikatsu Kanai, et al. · Journal of Pharmacological Sciences · 77
PDF
JPH203, an L-Type Amino Acid Transporter 1–Selective Compound, Induces Apoptosis of YD-38 Human Oral Cancer Cells
2014 · Dae-Woong Yun, Seul Ah Lee, et al. · Journal of Pharmacological Sciences · 76
PDF
Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation
2020 · Lili Quan, Ryuichi Ohgaki, et al. · Journal of Experimental & Clinical Cancer Research · 75
PDF
Efficient Recovery of Lignocellulolytic Enzymes of Spent Mushroom Compost from Oyster Mushrooms, Pleurotus spp., and Potential Use in Dye Decolorization
2013 · Seon-Hwa Lim, Yun-Hae Lee, et al. · Mycobiology · 75
High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas
2012 · Nobuyuki Yanagisawa, Masaaki Ichinoe, et al. · Journal of Clinical Pathology · 75
Molecular Mechanism of Ochratoxin A Transport in the Kidney
2010 · Naohiko Anzai, Promsuk Jutabha, et al. · Toxins · 74
PDF
Inhibition of l -type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment
2017 · Supak Yothaisong, Hasaya Dokduang, et al. · Tumor Biology · 69
Developing Potent Human Uric Acid Transporter 1 (hURAT1) Inhibitors
2011 · Michael F. Wempe, Promsuk Jutabha, et al. · Journal of Medicinal Chemistry · 69
Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout
2009 · Wako Urano, Atsuo Taniguchi, et al. · Annals of the Rheumatic Diseases · 68
Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor
2020 · Hiroki Okanishi, Ryuichi Ohgaki, et al. · Cancer Science · 66
PDF
LAT1‐specific inhibitor is effective against T cell‐mediated allergic skin inflammation
2019 · Keitaro Hayashi, Osamu Kaminuma, et al. · Allergy · 62
Coupling cell growth and biochemical pathway induction in Saccharomyces cerevisiae for production of (+)-valencene and its chemical conversion to (+)-nootkatone
2022 · Ziling Ye, Yanglei Huang, et al. · Metabolic Engineering · 61
Vascular endothelial growth factor contributes to lung vascular hyperpermeability in sepsis-associated acute lung injury
2020 · Kengo Tomita, Yuna Saito, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 49
PDF
Works count: 109
Citation count: 4,365
Year
Topic
Type